Cargando…
The deubiquitinase USP22 regulates PD-L1 degradation in human cancer cells
BACKGROUND: Many cancers evade immune surveillance by overexpressing PD-L1. PD-L1 interacted with its receptor PD-1, resulting in reduction of T cell proliferation and activation and thereafter cancer cell death mediated by T-lymphocyte. Understanding the mechanisms that regulate PD-L1 was of vital...
Autores principales: | Wang, Yu, Sun, Qingguo, Mu, Ning, Sun, Xiaoyang, Wang, Yingying, Fan, Songqing, Su, Ling, Liu, Xiangguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362500/ https://www.ncbi.nlm.nih.gov/pubmed/32665011 http://dx.doi.org/10.1186/s12964-020-00612-y |
Ejemplares similares
-
Inhibition of the deubiquitinase USP10 induces degradation of SYK
por: Yang, Jing, et al.
Publicado: (2020) -
Regulation of Bax-dependent apoptosis by mitochondrial deubiquitinase USP30
por: Yan, Ding, et al.
Publicado: (2021) -
USP7 and USP47 deubiquitinases regulate NLRP3 inflammasome activation
por: Palazón‐Riquelme, Pablo, et al.
Publicado: (2018) -
Targeting deubiquitinase USP28 for cancer therapy
por: Wang, Xiaofang, et al.
Publicado: (2018) -
The Regulations of Deubiquitinase USP15 and Its Pathophysiological Mechanisms in Diseases
por: Chou, Chon-Kit, et al.
Publicado: (2017)